334 related articles for article (PubMed ID: 9004818)
1. [Natural course and physiopathology of ascites in the cirrhotic patient].
Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
3. Ascites in liver diseases.
Gentilini P; Laffi G
Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
[TBL] [Abstract][Full Text] [Related]
4. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
6. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
Levy M; Wexler MJ
J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
[TBL] [Abstract][Full Text] [Related]
7. [The pathophysiology of ascites formation in cirrhosis of the liver].
Benjaminov FS
Harefuah; 2002 Aug; 141(8):721-5, 760. PubMed ID: 12222138
[TBL] [Abstract][Full Text] [Related]
8. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
9. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
11. [The renin-angiotensin-aldosterone system in liver cirrhosis].
Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
Gentilini P; Laffi G
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
[TBL] [Abstract][Full Text] [Related]
14. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
Karwa R; Woodis CB
Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
[TBL] [Abstract][Full Text] [Related]
15. [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function].
Toledo C; Ginés P; Arroyo V
Rev Med Chil; 1992 Feb; 120(2):180-7. PubMed ID: 1340557
[TBL] [Abstract][Full Text] [Related]
16. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
17. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
18. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
19. Review: the controversy over the pathophysiology of ascites formation in cirrhosis.
Wong F; Girgrah N; Blendis L
J Gastroenterol Hepatol; 1997 Jun; 12(6):437-44. PubMed ID: 9195401
[TBL] [Abstract][Full Text] [Related]
20. Splanchnic and systemic vasodilatation: the patient.
Tsai MH
J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
